MEP12109A - Reconstituted surfactants having improved properties - Google Patents

Reconstituted surfactants having improved properties

Info

Publication number
MEP12109A
MEP12109A MEP-121/09A MEP12109A MEP12109A ME P12109 A MEP12109 A ME P12109A ME P12109 A MEP12109 A ME P12109A ME P12109 A MEP12109 A ME P12109A
Authority
ME
Montenegro
Prior art keywords
improved properties
reconstituted surfactants
surfactants
relates
present
Prior art date
Application number
MEP-121/09A
Other languages
Bosnian (bs)
English (en)
Inventor
Jan Johansson
Tore Curstedt
Bengt Robertson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39079026&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP12109(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of MEP12109A publication Critical patent/MEP12109A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Fire-Extinguishing Compositions (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
MEP-121/09A 2006-10-13 2007-09-28 Reconstituted surfactants having improved properties MEP12109A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06021521 2006-10-13
PCT/IB2007/002841 WO2008044109A1 (en) 2006-10-13 2007-09-28 Reconstituted surfactants having improved properties

Publications (1)

Publication Number Publication Date
MEP12109A true MEP12109A (en) 2011-12-20

Family

ID=39079026

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-121/09A MEP12109A (en) 2006-10-13 2007-09-28 Reconstituted surfactants having improved properties
MEP-2016-20A ME02326B (me) 2006-10-13 2007-09-28 Rekonstituisani surfaktanti sa poboljšanim svojstvima

Family Applications After (1)

Application Number Title Priority Date Filing Date
MEP-2016-20A ME02326B (me) 2006-10-13 2007-09-28 Rekonstituisani surfaktanti sa poboljšanim svojstvima

Country Status (36)

Country Link
US (2) US8183210B2 (pt)
EP (1) EP2078038B1 (pt)
JP (2) JP5405307B2 (pt)
KR (1) KR101328851B1 (pt)
CN (2) CN101522711B (pt)
AR (2) AR063263A1 (pt)
AU (1) AU2007306075B2 (pt)
BR (1) BRPI0715317B1 (pt)
CA (1) CA2666344C (pt)
CL (1) CL2007002931A1 (pt)
CO (1) CO6400235A2 (pt)
CY (1) CY1114716T1 (pt)
DK (1) DK2078038T3 (pt)
EA (1) EA015802B1 (pt)
ES (1) ES2438727T3 (pt)
GE (1) GEP20125531B (pt)
HK (2) HK1134497A1 (pt)
HR (1) HRP20140052T1 (pt)
IL (1) IL198075A (pt)
JO (1) JO2963B1 (pt)
MA (1) MA31062B1 (pt)
ME (2) MEP12109A (pt)
MX (1) MX343064B (pt)
MY (1) MY148127A (pt)
NO (1) NO342038B1 (pt)
NZ (1) NZ576189A (pt)
PE (1) PE20081184A1 (pt)
PL (1) PL2078038T3 (pt)
PT (1) PT2078038E (pt)
RS (1) RS53172B (pt)
SI (1) SI2078038T1 (pt)
TN (1) TN2009000099A1 (pt)
TW (1) TWI388333B (pt)
UA (1) UA94477C2 (pt)
WO (1) WO2008044109A1 (pt)
ZA (1) ZA200902481B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2049554A4 (en) 2006-07-20 2011-06-29 Univ Rochester Medical Ct SYNTHETIC PULMONARY SURFACTANT AND USE THEREOF
EP1997502A1 (en) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
US8399406B2 (en) * 2009-06-05 2013-03-19 Chiesi Farmaceutici S.P.A. Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)
CN101948526B (zh) * 2010-09-02 2012-12-05 华东理工大学 一种肺泡表面活性蛋白质(sp-b和sp-c)的分离纯化方法
WO2013120058A2 (en) * 2012-02-09 2013-08-15 University Of Rochester Novel sp-b & sp-c peptides, synthetic lung surfactants, and use thereof
US20130303726A1 (en) * 2012-04-17 2013-11-14 Chiesi Farmaceutici S.P.A. Method for the preparation of surfactant peptides
WO2014079898A1 (en) 2012-11-21 2014-05-30 Chiesi Farmaceutici S.P.A. Reconstituted pulmonary surfactants
US10717777B2 (en) 2015-12-17 2020-07-21 The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Synthetic lung surfactant with enhanced stability and effectiveness
US11179446B2 (en) 2016-03-07 2021-11-23 Lundquist Institute For Biomedical Innovation At Harbor—Ucla Medical Center Compositions and method for administering PPARgamma agonists, surfactant peptides and phosopholipids
MA46034A (fr) * 2016-08-24 2021-04-28 Chiesi Farm Spa Formulation pharmaceutique stable comprenant une composition de surfactant pulmonaire reconstitué
EP4097128A1 (en) 2020-01-28 2022-12-07 Chiesi Farmaceutici S.p.A. Polypeptides having improved properties

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2163860A1 (en) * 1993-06-30 1995-01-12 Chung C. Hsu Method for preparing liposomes
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
US7065342B1 (en) * 1999-11-23 2006-06-20 Gofigure, L.L.C. System and mobile cellular telephone device for playing recorded music
ITMI20021058A1 (it) 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
EP2049554A4 (en) * 2006-07-20 2011-06-29 Univ Rochester Medical Ct SYNTHETIC PULMONARY SURFACTANT AND USE THEREOF
EP1997502A1 (en) 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
EP2022798A1 (en) 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides

Also Published As

Publication number Publication date
CY1114716T1 (el) 2016-10-05
BRPI0715317B1 (pt) 2021-10-05
KR20090083892A (ko) 2009-08-04
US20100004173A1 (en) 2010-01-07
NO20091441L (no) 2009-06-23
US20130079275A1 (en) 2013-03-28
TN2009000099A1 (en) 2010-08-19
AR113422A2 (es) 2020-04-29
TWI388333B (zh) 2013-03-11
CN103169947A (zh) 2013-06-26
AR063263A1 (es) 2009-01-14
JP5405307B2 (ja) 2014-02-05
CN101522711B (zh) 2013-11-13
NZ576189A (en) 2011-09-30
EP2078038B1 (en) 2013-11-20
CN101522711A (zh) 2009-09-02
JP2010505937A (ja) 2010-02-25
NO342038B1 (no) 2018-03-19
US8183210B2 (en) 2012-05-22
PL2078038T3 (pl) 2014-05-30
IL198075A (en) 2016-04-21
HRP20140052T1 (hr) 2014-02-28
EA200900373A1 (ru) 2009-10-30
JO2963B1 (en) 2016-03-15
JP2013241449A (ja) 2013-12-05
AU2007306075A1 (en) 2008-04-17
EP2078038A1 (en) 2009-07-15
CA2666344A1 (en) 2008-04-17
GEP20125531B (en) 2012-05-25
BRPI0715317A2 (pt) 2013-07-09
UA94477C2 (ru) 2011-05-10
ZA200902481B (en) 2010-07-28
PT2078038E (pt) 2013-12-12
PE20081184A1 (es) 2008-09-26
ME02326B (me) 2016-06-20
MX343064B (es) 2016-10-24
CN103169947B (zh) 2014-10-29
CO6400235A2 (es) 2012-03-15
HK1134497A1 (en) 2010-04-30
SI2078038T1 (sl) 2014-02-28
MX2009003638A (es) 2009-04-22
CA2666344C (en) 2017-04-18
WO2008044109A1 (en) 2008-04-17
TW200824705A (en) 2008-06-16
EA015802B1 (ru) 2011-12-30
MA31062B1 (fr) 2010-01-04
ES2438727T3 (es) 2014-01-20
AU2007306075B2 (en) 2012-08-09
RS53172B (en) 2014-06-30
HK1185274A1 (en) 2014-02-14
KR101328851B1 (ko) 2013-11-14
DK2078038T3 (da) 2013-12-02
IL198075A0 (en) 2011-08-01
CL2007002931A1 (es) 2008-03-24
MY148127A (en) 2013-02-28
US9238058B2 (en) 2016-01-19

Similar Documents

Publication Publication Date Title
MEP12109A (en) Reconstituted surfactants having improved properties
ATE544461T1 (de) Rekonstituierte tenside mit verbesserten eigenschaften
CY1118676T1 (el) Βελτιωμενη συνθεση ανασυσταμενου επιφανειοδραστικου η οποια περιεχει αναλογα της επιφανειοδραστικης πρωτεϊνης β (sp-b) και της επιφανειοδραστικης πρωτεϊνης c (sp-c)
PH12019500644A1 (en) Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
EA201000399A1 (ru) Композиции и способы использования проостровковых пептидов и их аналогов
PE20110023A1 (es) Composiciones inmunogenicas de antigenos de staphylococcus aureus
BRPI0813699A2 (pt) Formulações de proteína de fusão glp-1-fc
CR10405A (es) Formulaciones novedosas que establizan e inhiben la precipitacion de composiciones inmunogenicas
EP3533461A3 (en) Prame derived peptides and immunogenic compositions comprising these
WO2006136607A3 (de) Verwendung von hydrophobin-polypeptiden sowie konjugaten aus hydrophobin-polypeptiden mit wirk- oder effektstoffen und ihre herstellung sowie deren einsatz in der kosmetik
DE602005019416D1 (de) Zusammensetzung aus einem pulmonalen surfactant und einem von tnf stammenden peptid
ECSP10010516A (es) Uso de variantes de igf-i pegiladas para el tratamiento de trastornos neuromusculares
WO2013120058A3 (en) Novel sp-b & sp-c peptides, synthetic lung surfactants, and use thereof
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
MX2010001543A (es) Peptidos de surfactante pulmonar sintetico.
BRPI0707420A8 (pt) composições contendo peptídeos com aminoácidos e métodos não naturais do uso
DE602006020155D1 (de) Pharmazeutische wundheilungs-zusammensetzungen in ren und natriumhyaluronat
HRP20041058B1 (hr) Poboljšanje smjese sintetskih lipida za pripravke tenzida za ponovno uspostavljanje
TW200732002A (en) Lens care compositions having a persistent cleaning efficacy
MX2022004944A (es) Composiciones y metodos para minimizar la perdida de proteinas a concentraciones de proteinas bajas.